Embecta Corp. (EMBC)
5.115
-0.44
(-7.84%)
USD |
NASDAQ |
Sep 09, 16:00
5.115
0.00 (0.00%)
After-Hours: 16:08
Embecta Net Income (Quarterly) : 21.10M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 21.10M |
| March 31, 2026 | -4.10M |
| December 31, 2025 | 44.10M |
| September 30, 2025 | 26.40M |
| June 30, 2025 | 45.50M |
| March 31, 2025 | 23.50M |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 14.60M |
| June 30, 2024 | 14.70M |
| March 31, 2024 | 28.90M |
| December 31, 2023 | 20.10M |
| Date | Value |
|---|---|
| September 30, 2023 | 6.00M |
| June 30, 2023 | 15.20M |
| March 31, 2023 | 14.00M |
| December 31, 2022 | 35.20M |
| September 30, 2022 | -17.20M |
| June 30, 2022 | 62.40M |
| March 31, 2022 | 79.60M |
| December 31, 2021 | 98.80M |
| September 30, 2021 | 97.10M |
| June 30, 2021 | 104.70M |
| March 31, 2021 | 107.90M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Artivion, Inc. | -13.49M |
| Abbott Laboratories | 928.00M |
| AngioDynamics, Inc. | -11.40M |
| Alphatec Holdings, Inc. | -25.78M |
| AtriCure, Inc. | 8.955M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 271.70M |
| Total Expenses (Quarterly) | 250.60M |
| EPS Diluted (Quarterly) | 0.3606 |
| Enterprise Value | 1.598B |
| Gross Profit Margin (Quarterly) | 55.47% |
| Profit Margin (Quarterly) | 7.77% |
| Earnings Yield | 29.01% |
| Operating Earnings Yield | 89.05% |
| Normalized Earnings Yield | 41.83 |